Sequencing.com
Los Angeles
About Sequencing.com
Sequencing is the world’s first and only open operating system for DNA sequencing, storage, analysis, personalization, and application development. We are ushering in a new era of personal genome innovation for consumers, bioinformatics developers/startups, pharmaceutical companies, and health and wellness providers. Sequencing has been used by partners throughout the world to develop and market more than 100 DNA analysis apps. These apps analyze data from our own or any third party genetic test (including 23andMe, Ancestry.com, Illumina, Invitae, and Color) and provide straightforward reports covering the full range of information that can be obtained from DNA including personalized medicine, preventive health, preconception screening, rare disease screening, wellness optimization, genealogy, and genetic data exploration. Our DNA-as-a-service enables healthcare providers and wellness organizations to effortlessly customize their own genetic testing, analysis, and storage pipelines for almost any purpose, including the assessment of risk for thousands of diseases, the likelihood of experiencing medication reactions, and the personalization of wellness products and services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $5.0M
- Last round: Series Unknown (Jan 2024)
- Website: sequencing.com
- Phone: 833-544-0001
Industries & Categories
Genetics, Information Technology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/sequencing-com-39282 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.